CD44 and breast carcinoma: A high percentage of BCSCs enriched with CD44+CD24-/low phenotype was found harbored in basal-like tumors [4] and the phenotype was observed in ‘triple-negative’ breast cancer that responded poorly to chemotherapy [5].